# Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults

> **NCT06965881** · PHASE1 · TERMINATED · sponsor: **GRIN Therapeutics, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Tuberous Sclerosis Complex (TSC)
- Focal Cortical Dysplasia
- Other Neurological Disorders

## Interventions

- **DRUG:** Radiprodil with Carbamazepine
- **DRUG:** Radiprodil with Itraconazole

## Key facts

- **NCT ID:** NCT06965881
- **Lead sponsor:** GRIN Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-05-08
- **Primary completion:** 2025-07-08
- **Final completion:** 2025-07-08
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Study was terminated due to the lack of operational capabilities of the sites to segregate participants as needed.
- **Last updated:** 2025-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06965881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06965881, "Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT06965881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*